引用本文:江 灵,李 晟,王芝瑶,燕德敏,黄远帅,王雨涵.HCV核心抗原检测在丙型肝炎感染早期诊断中的应用研究[J].中国临床新医学,2022,15(12):1171-1174.
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 935次   下载 982 本文二维码信息
码上扫一扫!
分享到: 微信 更多
HCV核心抗原检测在丙型肝炎感染早期诊断中的应用研究
江 灵,李 晟,王芝瑶,燕德敏,黄远帅,王雨涵
646000 泸州,西南医科大学附属医院输血科(江 灵,黄远帅);646000 泸州,西南医科大学医学检验系(李 晟,王芝瑶,燕德敏);625099 四川,雅安市人民医院输血科(王雨涵)
摘要:
[摘要] 目的 探讨HCV核心抗原(HCV-cAg)检测在丙型肝炎感染早期诊断中的应用价值。方法 选择2020年1月至2021年7月西南医科大学附属医院接治的HCV-cAg阳性患者90例和丙型肝炎抗体(HCV-Ab)阳性患者164例作为研究对象,测定其血清谷丙转氨酶(ALT)和丙型肝炎病毒核酸(HCV-RNA)水平。以核酸检测结果为金标准,分析HCV-cAg检测在丙肝感染早期诊断中的有效性。结果 90例HCV-cAg阳性患者中,HCV-RNA阳性76例(84.44%),肝功能异常54例(60.00%)。164例HCV-Ab阳性患者中,HCV-RNA阳性114例(69.51%),肝功能异常75例(45.73%)。HCV-cAg阳性组的HCV-RNA阳性率和肝功能异常率都显著高于HCV-Ab阳性组(P<0.05),并且HCV-cAg的S/CO值与肝功能异常率存在关联性(P<0.05)。结论 HCV-cAg检测结果能反映肝功能状态,可用于丙型肝炎的早期筛查及疗效评估。
关键词:  丙型肝炎  核心抗原  丙型肝炎抗体  谷丙转氨酶  早期诊断
DOI:10.3969/j.issn.1674-3806.2022.12.14
分类号:R 512.6+3
基金项目:西南医科大学校级大创项目(编号:2021488)
A study on the application of HCV-cAg detection in early diagnosis of hepatitis C infection
JIANG Ling, LI Sheng, WANG Zhi-yao, et al.
Department of Blood Transfusion, the Affiliated Hospital of Southwest Medical University, Luzhou 646000, China
Abstract:
[Abstract] Objective To investigate the application value of hepatitis C virus core antigen(HCV-cAg) detection in early diagnosis of hepatitis C infection. Methods Ninety patients with HCV-cAg positive and 164 patients with hepatitis C virus antibody(HCV-Ab) positive who received treatment in the Affiliated Hospital of Southwest Medical University from January 2020 to July 2021 were selected as the research subjects. The levels of glutamic-pyruvic transaminase(ALT) and hepatitis C virus ribonucleic acid(HCV-RNA) in the patients′ serum were detected, and nucleic acid test results were used as the gold standard to analyze the effectiveness of HCV-cAg detection in the early diagnosis of hepatitis C infection. Results Among the 90 cases of HCV-cAg positive specimens, 76 cases were positive for HCV-RNA, with the positive rate being 84.44%, and 54 cases were abnormal liver function, with the abnormal rate being 60.00%. Among the 164 cases of HCV-Ab positive, 114 cases(69.51%) were HCV-RNA positive, and 75 cases(45.73%) had abnormal live function. The rate of positive HCV-RNA and abnormal liver function in the HCV-cAg positive group were significantly higher than those in the HCV-Ab positive group(P<0.05), and the sample′s optical density/cut-off(S/CO) value of HCV-cAg was associated with abnormal liver function(P<0.05). Conclusion The detection results of HCV-cAg can reflect the liver function status, and can be used for early screening and efficacy evaluation of hepatitis C.
Key words:  Hepatitis C  Hepatitis C virus core antigen(HCV-cAg)  Hepatitis C virus antibody(HCV-Ab)  Glutamic-pyruvic transaminase(ALT)  Early diagnose